Date of Award
5-2019
Document Type
Thesis
Degree Name
Master of Science (MS)
College/School
College of Science and Mathematics
Department/Program
Biology
Thesis Sponsor/Dissertation Chair/Project Chair
Mitchell Sitnick
Committee Member
Quinn Vega
Committee Member
John Gaynor
Abstract
Saponins are a broad class of functionally diverse phytochemicals that have been shown to exhibit antihyperglycemic, antihyperlipidemic, anti-inflammatory, and anticancer effects. Through in vitro and in vivo experimentation, Astragaloside IV (AsIV) has been shown to regulate glycogen synthesis through protein kinase B (AKT)-mediated phosphorylation of glycogen synthase kinase 3-beta (GSK-3β). Along with control of glucose homeostasis, AKT activation is also an important regulator of protein synthesis via the downstream phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase beta-1 (S6K1). Because AsIV can activate this pathway to stimulate glucose metabolism, it is possible that it can also promote protein synthesis as well since these two regulatory processes utilize the same pathway. In order to determine the effect of AsIV on protein synthetic pathways, C2C12 murine muscle cells were treated with AsIV and the phosphorylation levels of key enzymes were assessed.
We found that AsIV induced phosphorylation of key protein synthetic targets in a time-dependent manner, with the greatest increases in phosphorylation after two hours of AsIV treatment. However, this effect was not seen when cells were serum-starved prior to AsIV treatment. Lastly, AsIV was able to increase GSK-3β phosphorylation in cells treated with dexamethasone first. These findings help to further understand the molecular changes that occur in muscle cells treated with AsIV.
File Format
Recommended Citation
Tuohy, Kyle James, "Effects of Astragaloside IV on GSK-3β and S6K1 Phosphorylation in C2C12 Muscle Cells" (2019). Theses, Dissertations and Culminating Projects. 287.
https://digitalcommons.montclair.edu/etd/287